Non-solvent type curable composition, cured layer using the same, color filter including the cured layer, display device including the cured layer and manufacturing method of the cured layer
US-2024084194-A1 · Mar 14, 2024 · US
US12365833B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12365833-B2 |
| Application number | US-202118011485-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 20, 2021 |
| Priority date | Sep 16, 2020 |
| Publication date | Jul 22, 2025 |
| Grant date | Jul 22, 2025 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed are a curable composition, a cured layer manufactured using the curable composition, and a color filter including the cured layer. The curable composition includes a quantum dot and a polymerizable compound, wherein the polymerizable compound includes a first polymerizable compound serving as a hydrogen bond donor and a second polymerizable compound serving as a hydrogen bond acceptor, and the first polymerizable compound and second polymerizable compound each independently include a (meth)acrylate group at at least one terminal end.
Opening claim text (preview).
What is claimed is: 1. A curable composition, comprising a quantum dot and a polymerizable compound, wherein the polymerizable compound comprises a first polymerizable compound serving as a hydrogen bond donor and a second polymerizable compound serving as a hydrogen bond acceptor, and the first polymerizable compound and second polymerizable compound each independently comprises a (meth)acrylate group at at least one terminal end, and wherein the second polymerizable compound is represented by Chemical Formula 2: wherein, in Chemical Formula 2, R c and R d are each independently a hydrogen atom or a substituted or unsubstituted C1 to C10 alkyl group, L c and L d are each independently a single bond, a substituted or unsubstituted C1 to C20 alkylene group, or a substituted or unsubstituted C6 to C20 arylene group, and Y is a sulfur atom, *—C(═O)—*, a C1 to C10 alkylene group substituted with a fluorine atom or *—NR e (R e is a C1 to C10 alkyl group or a C6 to C20 aryl group)-*. 2. The curable composition of claim 1 , wherein the first polymerizable compound is represented by Chemical Formula 1: wherein, in Chemical Formula 1, R a and R b are each independently a hydrogen atom or a substituted or unsubstituted C1 to C10 alkyl group, L a and L b are each independently a single bond, a substituted or unsubstituted C1 to C20 alkylene group, or a substituted or unsubstituted C6 to C20 arylene group, and X is a C1 to C10 alkylene group substituted with a hydroxyl group, a C1 to C10 alkylene group substituted with an amino group, or *—NH—*. 3. The curable composition of claim 1 , wherein the first polymerizable compound has a viscosity greater than 6.2 cps and a vapor pressure less than 1×10 −3 torr at 25° C. 4. The curable composition of claim 1 , wherein the first polymerizable compound represented by any one of Chemical Formula 1-1 to Chemical Formula 1-3: 5. The curable composition of claim 1 , wherein the second polymerizable compound has a viscosity of less than or equal to 6.2 cps and a vapor pressure of greater than or equal to 1×10 −3 torr at 25° C. 6. The curable composition of claim 1 , wherein the second polymerizable compound is represented by any one of Chemical Formula 2-2 to Chemical Formula 2-5: 7. The curable composition of claim 1 , wherein the curable composition is a solvent-free curable composition. 8. The curable composition of claim 7 , wherein the solvent-free curable composition comprises 5 wt % to 60 wt % of the quantum dot; and 40 wt % to 95 wt % of the polymerizable compound based on the total amount of the solvent-free curable composition. 9. The curable composition of claim 1 , wherein the curable composition further comprises a polymerization initiator, a light diffusing agent, a binder resin, or a combination thereof. 10. The curable composition of claim 9 , wherein the light diffusing agent comprises barium sulfate, calcium carbonate, titanium dioxide, zirconia, or a combination thereof. 11. The curable composition of claim 1 , wherein the curable composition further comprises a solvent. 12. The curable composition of claim 11 , wherein the curable composition comprises 1 wt % to 40 wt % of the quantum dot; 1 wt % to 20 wt % of the polymerizable compound; and 40 wt % to 80 wt % of the solvent based on the total amount of the curable composition. 13. The curable composition of claim 1 , wherein the curable composition further comprises a polymerization inhibitor; malonic acid; 3-amino-1,2-propanediol; a silane-based coupling agent; a leveling agent; a fluorine-based surfactant; or a combination thereof. 14. A cured layer manufactured using the curable composition of claim 1 . 15. A color filter comprising the cured layer of claim 14 .
with zinc or cadmium · CPC title
containing phosphorus · CPC title
with zinc cadmium · CPC title
characterised by colouring agents · CPC title
from unsaturated acids or derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.